These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 20945138)

  • 21. Effect of atorvastatin on the intravenous and oral pharmacokinetics of verapamil in rats.
    Choi DH; Chang KS; Hong SP; Choi JS; Han HK
    Biopharm Drug Dispos; 2008 Jan; 29(1):45-50. PubMed ID: 17941000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of loratadine in human plasma by HPLC with fluorescence detector and study on its bioavailability.
    Xu XJ; Shang EX; Qiu FR; Mao GG; Xiang BR
    Yao Xue Xue Bao; 2004 Feb; 39(2):123-6. PubMed ID: 15127620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of oral epigallocatechin gallate on the pharmacokinetics of nicardipine in rats.
    Choi JS; Burm JP
    Arch Pharm Res; 2009 Dec; 32(12):1721-5. PubMed ID: 20162400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of liver fibrosis on verapamil pharmacokinetics in rats.
    Chen M; Xu D; Hu XL; Wang H
    Clin Exp Pharmacol Physiol; 2008 Mar; 35(3):287-94. PubMed ID: 17973928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of oral epigallocatechin gallate on the oral pharmacokinetics of verapamil in rats.
    Chung JH; Choi DH; Choi JS
    Biopharm Drug Dispos; 2009 Mar; 30(2):90-3. PubMed ID: 19226653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circadian time-effect of orally administered loratadine on plasma pharmacokinetics in mice.
    Dridi D; Ben-Attia M; Sani M; Djebli N; Sauvage FL; Boughattas NA
    Chronobiol Int; 2008 Jul; 25(4):533-47. PubMed ID: 18622814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of tesmilifene, a substrate of CYP3A and an inhibitor of P-glycoprotein, on the pharmacokinetics of intravenous and oral docetaxel in rats.
    Choi YH; Suh JH; Lee JH; Cho IH; Lee MG
    J Pharm Pharmacol; 2010 Aug; 62(8):1084-8. PubMed ID: 20663044
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of the loratadine gel for enhanced transdermal delivery.
    Song JH; Shin SC
    Drug Dev Ind Pharm; 2009 Aug; 35(8):897-903. PubMed ID: 19241201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of cilostazol on the pharmacokinetics of carvedilol after oral and intravenous administration in rats.
    Lim TH; Cho YA; Choi DH
    J Physiol Pharmacol; 2015 Aug; 66(4):591-7. PubMed ID: 26348083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of P-glycoprotein in the intestinal absorption and clinical effects of morphine.
    Kharasch ED; Hoffer C; Whittington D; Sheffels P
    Clin Pharmacol Ther; 2003 Dec; 74(6):543-54. PubMed ID: 14663457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of ketoconazole on the intestinal metabolism, transport and oral bioavailability of K02, a novel vinylsulfone peptidomimetic cysteine protease inhibitor and a P450 3A, P-glycoprotein dual substrate, in male Sprague-Dawley rats.
    Zhang Y; Hsieh Y; Izumi T; Lin ET; Benet LZ
    J Pharmacol Exp Ther; 1998 Oct; 287(1):246-52. PubMed ID: 9765344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of myricetin on the bioavailability of carvedilol in rats.
    Lee W; Woo ER; Choi JS
    Pharm Biol; 2012 Apr; 50(4):516-22. PubMed ID: 22132944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of the antimalarial drug, AQ-13, in rats and cynomolgus macaques.
    Ramanathan-Girish S; Catz P; Creek MR; Wu B; Thomas D; Krogstad DJ; De D; Mirsalis JC; Green CE
    Int J Toxicol; 2004; 23(3):179-89. PubMed ID: 15204721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The cytochrome P450 3A4 inhibitor itraconazole markedly increases the plasma concentrations of dexamethasone and enhances its adrenal-suppressant effect.
    Varis T; Kivistö KT; Backman JT; Neuvonen PJ
    Clin Pharmacol Ther; 2000 Nov; 68(5):487-94. PubMed ID: 11103751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A retrospective, open-label analysis of the population pharmacokinetics of a single 10-mg dose of loratadine in healthy white Jordanian male volunteers.
    Salem II; Najib NM; Idkaidek NM
    Clin Ther; 2010 Feb; 32(2):391-5. PubMed ID: 20206796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of resveratrol on the pharmacokinetics of oral and intravenous nicardipine in rats: possible role of P-glycoprotein inhibition by resveratrol.
    Choi JS; Choi BC; Kang KW
    Pharmazie; 2009 Jan; 64(1):49-52. PubMed ID: 19216231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced bioavailability of verapamil after oral administration with hesperidin in rats.
    Piao YJ; Choi JS
    Arch Pharm Res; 2008 Apr; 31(4):518-22. PubMed ID: 18449511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancement of oral bioavailability of paclitaxel after oral administration of Schisandrol B in rats.
    Jin J; Bi H; Hu J; Zhong G; Zhao L; Huang Z; Huang M
    Biopharm Drug Dispos; 2010 May; 31(4):264-8. PubMed ID: 20437465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of quinidine on antinociception and pharmacokinetics of morphine in rats.
    Okura T; Morita Y; Ito Y; Kagawa Y; Yamada S
    J Pharm Pharmacol; 2009 May; 61(5):593-7. PubMed ID: 19405997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of atorvastatin and its hydroxy metabolites in rats and the effects of concomitant rifampicin single doses: relevance of first-pass effect from hepatic uptake transporters, and intestinal and hepatic metabolism.
    Lau YY; Okochi H; Huang Y; Benet LZ
    Drug Metab Dispos; 2006 Jul; 34(7):1175-81. PubMed ID: 16624870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.